Lina-DKD 5mg Tablet
Marketer
La Renon Healthcare Pvt Ltd
Salt Composition
Linagliptin (5mg)
Overview Lina-DKD 5mg Tablet
D-Kinase 5mg tablets are indicated for managing type 2 diabetes. Combined with a balanced diet and regular physical activity, they help regulate blood glucose, mitigating risks like vision impairment and kidney complications. This medication is typically prescribed when lifestyle changes and other treatments fail to adequately control blood sugar. Your physician may recommend it as monotherapy or in conjunction with other antidiabetic agents. It can be administered with or without food, with dosage adjusted according to your individual needs and blood sugar readings. Always adhere strictly to your doctor's instructions; discontinue use only under their guidance. Continued adherence to your prescribed diet and exercise regimen is crucial. Lifestyle significantly impacts diabetes management. Hypoglycemia is a common side effect; familiarize yourself with its symptoms (lightheadedness, sweating, dizziness, fainting) and carry glucose tablets for prompt relief. Nasopharyngitis is another potential side effect. Report persistent or concerning side effects to your doctor. Prior to commencing treatment, inform your doctor of any pre-existing kidney, heart, or pancreatic conditions, and any other medications you are taking, as interactions may occur. Pregnant or lactating women must consult their physician. Alcohol consumption should be limited due to increased hypoglycemia risk. Regular blood glucose and kidney function monitoring may be necessary to assess treatment efficacy.
Uses of Lina-DKD 5mg Tablet
Managing Type 2 Diabetes
Major Benefits of Lina-DKD 5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 5mg Lina-DKD tablet whole; avoid crushing, chewing, or breaking it. While you can take it with or without food, consistency is key—maintain a regular daily schedule.
Common Side effects of Lina-DKD 5mg Tablet:
- Hypoglycemia (low blood glucose level)
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Cough
- Vomiting
- Diarrhea
- Constipation
How to use Lina-DKD 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 5mg Lina-DKD tablet whole; do not damage it by chewing, crushing, or breaking. While it can be taken with or without food, consistent timing is recommended.
How Lina-DKD 5mg Tablet works:
Lina-DKD 5mg tablets are used to manage diabetes. Their mechanism involves stimulating insulin secretion by the pancreas and suppressing counter-regulatory hormones. This dual action lowers both fasting and postprandial glucose concentrations.
SAFETY ADVICE
AlcoholUNSAFE
Combining Lina-DKD 5mg Tablet and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Lina-DKD 5mg tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Lina-DKD 5mg Tablet use while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Lina-DKD 5mg Tablets.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, the 5mg Lina-DKD tablet is considered safe and requires no dosage modification. Nevertheless, its use should be approached cautiously in patients experiencing end-stage renal disease (ESRD) or undergoing dialysis.
LiverSAFE IF PRESCRIBED
Patients with liver disease can generally use Lina-DKD 5mg tablets without altering the dosage. However, its use is contraindicated in patients experiencing severe hepatic impairment.
What if you forget to take Lina-DKD 5mg Tablet :
Should you forget a Lina-DKD 5mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Lina-DKD 5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Purine-quinazoline hybrid |
| Developing Habits | No. |
| Type of Treatment | Diabetes Treatment |
| Action Class | Dipeptidyl peptidase-4 inhibitors |





